Table 1.

Analysis of variance components for MLN disease severity evaluated across two to three environments with four different F₃ mapping populations

Trait	σ 2 G	σ 2 GE	σ 2 e	h 2
CML543 × LaPostaSeqC7-F71
MLN-early	0.05*	0.02*	0.17	0.58
MLN-late	0.06*	0.06*	0.23	0.52
CML543 × CML444
MLN-early	0.04*	0.01*	0.18	0.53
MLN-late	0.07*	0.02*	0.24	0.60
CML539 × CML444
MLN-early	0.02*	0.01	0.21	0.34
MLN-late	0.03*	0.02*	0.20	0.44
M037 × CML144
MLN-early	0.08*	0.001	0.09	0.83
MLN-late	0.21*	0.001	0.15	0.89
Across three pops
MLN-early	0.03*	0.002*	0.19	0.25
MLN-late	0.04*	0.03	0.15	0.35

*Significance at < 0.05 level of probability